Plenge Robert M — SEC insider filings
SEC reporting owner CIK 1773367. 8 insider filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-06-16 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 732 shares, $44,754 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 57.
- Largest priced transaction: sale of 732 shares @ $61.14 ($44,754) in BRISTOL MYERS SQUIBB CO, filed 2023-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 5 | — | 1 leg · 732 sh · $44,754 | 51 |
| Translate Bio, Inc. (TBIO) | Director | 2 | — | — | 5 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | 1 | — | — | 1 |
Insider filings — Plenge Robert M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 6,140 @ $0 | EDGAR |
| 2026-03-12 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 1,107 @ $0 · Other (J): 124 @ $0 · Tax withholding (F): 436 @ $60.13 · Option exercise (M): 2,342 @ $0 · Other (J): 253 @ $0 · Tax withholding (F): 927 @ $60.13 · +8 more | EDGAR |
| 2025-03-12 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 1,165 @ $0 · Other (J): 80 @ $0 · Tax withholding (F): 482 @ $63.11 · Option exercise (M): 1,107 @ $0 · Other (J): 193 @ $0 · Tax withholding (F): 406 @ $63.11 · +12 more | EDGAR |
| 2024-03-12 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 994 @ $0 · Other (J): 157 @ $0 · Tax withholding (F): 246 @ $53.79 · Option exercise (M): 1,164 @ $0 · Other (J): 201 @ $0 · Tax withholding (F): 283 @ $53.79 · +10 more | EDGAR |
| 2023-12-05 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 616 @ $0 · Tax withholding (F): 274 @ $50.10 · Option exercise (M): 616 (derivative) @ $0 | EDGAR |
| 2023-08-07 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Sale (S): 732 @ $61.14 | EDGAR |
| 2021-09-14 | 4 | Translate Bio, Inc. (TBIO) | Sale (S): 37,800 (derivative) @ $0 · Sale (S): 18,900 (derivative) @ $0 · Sale (S): 18,900 (derivative) @ $0 · Sale (S): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Translate Bio, Inc. (TBIO) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773367 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs